24/7 QualityMeds Blog – Access to Medicines & Healthcare Updates in India

Belzutifan ( Welireg ) cost, availability and access in India Belzutifan, marketed as Welireg, is a targeted therapy used for certain patients with von Hippel-Lindau (VHL) disease and advanced renal cell carcinoma (RCC). As an innovative HIF-2α inhibitor, belzutifan provides an important treatment option for patients with serious and potentially difficult-to-treat cancers. However, for patients in countries where the medicine is not readily available through regular commercial channels, obtaining belzutifan can involve a different process from purchasing a routinely stocked prescription medicine. In India, the overall belzutifan (Welireg) cost may therefore depend not only on the medicine itself but also on how it is accessed, sourced, imported and supplied to the patient. Understanding these factors can help patients and families have more realistic expectations about the final treatment expense. About Belzutifan Belzutifan is the active ingredient in Welireg and belongs to a class ...

If you think cancer treatment starts with a doctor’s prescription, you may be missing an important part of the story. A prescription is often the result of several clinical decisions and evaluations that happen beforehand. So, when a doctor recommends Truqap (capivasertib) , four important things have usually already taken place. These steps help doctors understand the cancer, review previous therapies, identify relevant biomarkers, and assess the patient's overall health before deciding whether the medicine is appropriate. Step 1: Finding the Type of Breast Cancer Doctors do not make treatment decisions based only on where the cancer is located. They also look at the biological characteristics of the cancer, including whether it is hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative . This information can influence treatment planning and helps doctors select medicines based on the specific characteristics of the disease. For eligible adults ...

Buy burosumab-twza injection in India For patients and families managing rare disorders such as X-linked hypophosphatemia (XLH) or tumor-induced osteomalacia (TIO), the cost of treatment can be an important consideration. Burosumab-twza, marketed as Crysvita, is a targeted therapy designed to address the underlying FGF23-driven phosphate imbalance associated with these conditions. However, there is no single fixed burosumab-twza price in India that applies to every patient. The overall amount depends on several factors, including the prescribed dose, treatment frequency, international sourcing, import-related expenses, taxes, documentation, shipping and currency exchange rates. What is Burosumab-twza? Burosumab-twza is a recombinant human monoclonal IgG1 antibody that targets and inhibits fibroblast growth factor 23 (FGF23). By inhibiting excess FGF23, it helps restore phosphate balance and support bone health. Crysvita is supplied as a subcutaneous injection in single-dose vials avai...